Barbiturate Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Ultra-Short, Short-Acting, Long-Acting, and Combination Drugs), By Disease Type (Epilepsy, Insomnia, and Sedation), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1004975 | Industries : Healthcare | Published On :January 2024 | Page Count : 215

Barbiturate Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Ultra-Short, Short-Acting, Long-Acting, and Combination Drugs), By Disease Type (Epilepsy, Insomnia, and Sedation), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Barbiturate Drugs market estimated at USD 489.9 million in 2022 and which expected, at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. Key players in the Barbiturate Drugs market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Barbiturate Drugs market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

BARBITURATE DRUGS MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Increased Prevalence of Neurological Disorders
Explanation: The rising incidence of neurological disorders, such as epilepsy and certain types of seizures, has contributed to the demand for barbiturate drugs. Barbiturates, known for their central nervous system depressant properties, are often prescribed in the management of neurological conditions. The growing patient pool with neurological disorders is a significant driver propelling the barbiturate drugs market.
Restraint: Side Effects and Risk of Abuse
Explanation: One of the key restraints in the barbiturate drugs market is the potential for side effects and the risk of abuse. Barbiturates are associated with a range of adverse effects, including sedation, dependence, and respiratory depression. The potential for misuse and addiction has led to increased caution in prescribing these drugs, contributing to a restraint in their market growth. The medical community is often exploring alternative medications with a more favorable safety profile.

How are Segments Performing in the Global Barbiturate Drugs Market?

Barbiturate Drugs Drug Type Segment Breakdown
According to Analytical Market Research, the Barbiturate Drugs market by Drug Type is segmented into Ultra-Short, Short-Acting, Long-Acting, and Combination Drugs.
Barbiturate Drugs Disease Type Segment Breakdown
According to Analytical Market Research, based on Disease Type, the market is segmented into Epilepsy, Insomnia, and Sedation.
Barbiturate Drugs Distribution Channel Segment Breakdown
According to Analytical Market Research, based on Distribution Channel the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Others.
Barbiturate Drugs Geographic Exploration
According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Barbiturate Drugs

The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.
• For Instance, in Jun 2021, Ethypharm bought Altan Pharma, a major manufacturer of hospital injectables. This transaction is expected to help the company obtain market access in Spain.

Noticeable Players Functioning in The Global Barbiturate Drugs Market Include:

• Par Pharmaceutical
• Akorn Operating Company LLC
• SAMARTH LIFE SCIENCES PVT. LTD
• Ethypharm
• Abbott
• Centurion Healthcare Private Limited
• Intas Pharmaceuticals Ltd. Source

KEY BREAKDOWN: Barbiturate Drugs Market

By Drug Type:
• Ultra-Short
• Short-Acting
• Long-Acting
• Combination Drugs
By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• Others
By Disease Type:
• Epilepsy
• Insomnia
• Sedation
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o U.K.
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

1. Research Methodology
1.1. Global Barbiturate Drugs Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Barbiturate Drugs Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Distribution Channels
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Barbiturate Drugs Market Outlook: Drug Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Drug Type, 2023 – 2030
4.3.2.1. Ultra-Short
4.3.2.2. Short-Acting
4.3.2.3. Long-Acting
4.3.2.4. Combination Drugs
4.4. Global Barbiturate Drugs Market Outlook: Distribution Channel
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
4.4.2.1. Hospital
4.4.2.2. Clinic
4.4.2.3. Ambulatory Surgical Centre
4.5. Global Barbiturate Drugs Market Outlook: Disease Type
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
4.5.3. Epilepsy
4.5.4. Insomnia
4.5.5. Sedation
5. Global Barbiturate Drugs Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Drug Type
6.3.3. By Distribution Channel
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
6.5.1. Ultra-Short
6.5.2. Short-Acting
6.5.3. Long-Acting
6.5.4. Combination Drugs
6.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
6.6.1. Hospital
6.6.2. Clinic
6.6.3. Ambulatory Surgical Centre
6.7. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
6.7.1. Epilepsy
6.7.2. Insomnia
6.7.3. Sedation
7. Europe Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Drug Type
7.3.3. By Distribution Channel
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
7.5.1. Ultra-Short
7.5.2. Short-Acting
7.5.3. Long-Acting
7.5.4. Combination Drugs
7.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
7.6.1. Hospital
7.6.2. Clinic
7.6.3. Ambulatory Surgical Centre
7.7. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
7.7.1. Epilepsy
7.7.2. Insomnia
7.7.3. Sedation
8. Asia Pacific Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Drug Type
8.3.3. By Distribution Channel
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
8.5.1. Ultra-Short
8.5.2. Short-Acting
8.5.3. Long-Acting
8.5.4. Combination Drugs
8.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
8.6.1. Retail Pharmacies
8.6.2. Hospital Pharmacies
8.6.3. Others
8.7. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
8.7.1. Epilepsy
8.7.2. Insomnia
8.7.3. Sedation
9. Latin America Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Drug Type
9.3.3. By Distribution Channel
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
9.5.1. Ultra-Short
9.5.2. Short-Acting
9.5.3. Long-Acting
9.5.4. Combination Drugs
9.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
9.6.1. Retail Pharmacies
9.6.2. Hospital Pharmacies
9.6.3. Others
9.7. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
9.7.1. Epilepsy
9.7.2. Insomnia
9.7.3. Sedation
10. Middle East & Africa Barbiturate Drugs Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Drug Type
10.3.3. By Distribution Channel
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Drug Type, 2023 – 2030
10.5.1. Ultra-Short
10.5.2. Short-Acting
10.5.3. Long-Acting
10.5.4. Combination Drugs
10.6. Market Size (US$ Mn) and Forecast By Distribution Channel, 2023 – 2030
10.6.1. Retail Pharmacies
10.6.2. Hospital Pharmacies
10.6.3. Others
10.7. Market Size (US$ Mn) and Forecast By Disease Type, 2023 – 2030
10.7.1. Epilepsy
10.7.2. Insomnia
10.7.3. Sedation
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Intas Pharmaceuticals Ltd. Source.
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Par Pharmaceutical
11.3.3. Akorn Operating Company LLC
11.3.4. SAMARTH LIFE SCIENCES PVT. LTD
11.3.5. Ethypharm
11.3.6. Abbott
11.3.7. Centurion Healthcare Private Limited